With our vast experience and expertise, Cryoport Systems is proud to be featured in reputable industry publications. Our subject matter experts offer their insights and input into life sciences topics in these articles.
Uniting a Cell and Gene Kingdom in Article with the Medicine MakerBoth Cryoport Systems’ own Robert Jones, Vice President of Global BioServices, and Mark Sawicki, President, CEO, and Chief Scientific Officer, shared details of our recently announced...
Location, infrastructure boost NJ’s biotech, life sciences industriesNJBIZ interviewed Cryoport Systems’ CEO, Mark Sawicki, about Cryoport Systems’ expansion into BioServices and our Morris Plains, NJ facility location in an article...
Standardize for Success with Mark Sawicki for The Medicine MakerDr. Mark Sawicki, Cryoport System’s CEO, shared his expertise on the future of regenerative medicine and the top challenges facing the industry today with The Medicine Maker.
New Strategic Partnership with Syneos Health to Advance Cell & Gene TherapiesCryoport, Inc. is excited to announce a new strategic partnership with Syneos Health, a fully integrated biopharmaceutical solutions organization.
Life Sciences Review Awards MVE Bio The Top Clinical Lab Equipment CompanyA salient aspect of biological research concerns collecting and preserving biological samples and materials for analysis. Since samples often degrade in the time between collection and analysis...
Cryoport and Cell Matters Collaboration Aids in the Standardization of Cell Therapy Supply Chain ProcessesA salient aspect of biological research concerns collecting and preserving biological samples and materials for analysis. Since samples often degrade in the time between collection and analysis...
RegMedNet Highlights Cryoport’s First Two Global Supply Chain CentersCryoport Systems' first two Global Supply Chain Centers in Morris Plains, New Jersey and Houston, Texas will provide critical support to major biotech companies around the world...
Cryoport Expands Global Supply Chain Network through Recent Acquisition of Cell&Co BioServicesThe recent acquisition of of Cell&Co BioServices by Cryoport, Inc. will help to expand global service offerings by generating opportunities for clinical trial and cell and gene therapy developers in Europe.